Alixorexton
N-[(15S,16R)-10-oxo-8,18-dioxa-11-azatetracyclo[17.2.2.02,7.011,16]tricosa-2,4,6-trien-15-yl]methanesulfonamide
Molecular Identity
Alixorexton
N-[(15S,16R)-10-oxo-8,18-dioxa-11-azatetracyclo[17.2.2.02,7.011,16]tricosa-2,4,6-trien-15-yl]methanesulfonamide
PubChem CID: 156417714
2D Structure
Properties
C21H30N2O5S
Molecular Formula
422.50
Molecular Weight
g/mol
422.1875
Exact Mass
Da
2.1
XLogP
Drug-like (Lipinski: < 5)
93.3
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
671
Complexity
SMILES
Canonical SMILES
SMILES: CS(=O)(=O)NC1CCCN2C1COC3CCC(CC3)C4=CC=CC=C4OCC2=OIsomeric SMILES
SMILES: CS(=O)(=O)N[C@H]1CCCN2[C@H]1COC3CCC(CC3)C4=CC=CC=C4OCC2=OSynonyms(20)
Alixorexton2648347-56-0ALKS2680ALKS 2680ALKS-2680N-((21S,24S,52R,53S)-6-oxo-3,8-dioxa-5(2,1)-piperidina-1(1,2)-benzena-2(1,4)-cyclohexanacyclooctaphane-53-yl)methanesulfonamidealixorexton [INN]Alixorexton (USAN/INN)ALIXOREXTON [USAN]3BRW4ARU66SCHEMBL23424870SCHEMBL23425231GTPL13879ALIXOREXTON (ALKS 2680)EX-A12469
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Alixorexton
Loading drug network...